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Chromium (Cr) is a well-documented animal
and human carcinogen (1). The biological and
genotoxic effects of Cr exposure vary, depend-
ing on intracellular Cr chemistry in the cell
type of interest. Due to its rapid uptake by nor-
mal cellular anion transport mechanisms,
Cr(VI) has been considered the primary car-
cinogenic form. However, reduced states of Cr
are likely to participate in cellular redox interac-
tions contributing to oxidative stress, which can
have genotoxic outcomes. Within cells, Cr(VI)
is reduced to lower valencies (V to II) by a vari-
ety of reductants, including cellular thiols (e.g.,
glutathione [GSH]), NADPH, and ascorbate,
to form reactive oxygen species (ROS), thiyl,
and carbon-based radicals [reviewed in
Kaltreider et al. (2) and Liu et al. (3)]. The
complex intracellular reduction chemistry of Cr
can produce DNA damage, Cr-mediated DNA
adducts, DNA–DNA and DNA–protein cross-
links, and mutations [reviewed in DeFlora et al.
(4) and Klein (5)]. Cr can also inhibit DNA
replication and repair [reviewed in Snow (6)],
alter gene expression (7,8), activate stress-
response pathways (2,9), trigger apoptosis
(10,11), and damage chromosomes [reviewed
in DeFlora et al. (4) and Klein (5)].
Using soluble chromate salts and insoluble
barium chromate (BaCrO4;Aldrich Chemicals,
Milwaukee, WI, USA), we studied the geno-
toxic effects of Cr in Chinese hamster G12
lung cells. These transgenic cells allow the
characterization of a mixed spectrum of geno-
toxic outcomes that may include genetic muta-
tions, transgene deletions, and epigenetic gene
silencing caused by aberrant DNA hyperme-
thylation. In previous studies we have shown
that the gpt transgene in G12 cells can be
mutated or otherwise inactivated by numerous
mutagens and carcinogens, including ultra-
violet (UV) radiation, N-methyl-N´-nitro-
N-nitrosoguanidine (MNNG), X-rays,
bleomycin, nickel, chromate, 17β -estradiol,
diethylstilbestrol (DES), nitric oxide, and oxi-
dant generators such as glucose oxidase. The
mutation spectrum induced by each of these
agents differs significantly. For example,
MNNG and UV induce primarily base-
substitution mutations (12,13), X-rays and
bleomycin induce frequent deletions (13), and
carcinogenic nickel induces DNA methylation
epimutations (variants) almost exclusively (14).
The nickel effect involves nickel, histone, and
chromatin interactions in the DNA that
promote condensation of heterochromatin in
the vicinity of the transgene (14,15).
In support of the concept that chemical
and physical carcinogens may exert their effects
by interacting with a variety of cellular
processes, we found that DES and X-rays can
produce a mixed spectrum of DNA mutations
(e.g., deletions and point mutations) and
epimutations (hypermethylation) in the trans-
genic gpt target of G12 cells (16). These obser-
vations prompted us to reexamine the
mutagenic spectrum induced by Cr in these
cells to investigate whether DNA hypermethy-
lation could be detected in any of the nondele-
tion mutants. Molecular analysis of a panel of
chromate-induced mutants shows a mixture of
deletions and epimutations (or variants), with
the deletion versus methylation frequencies
being similar to those induced by X-rays in
these cells. In contrast, studies with insoluble
BaCrO4 have provided substantial evidence of
gpt deletions but no evidence of altered DNA
methylation.
Materials and Methods
Cell Culture and Generation of gpt–
Mutants or Methylation Variants
The G12 gpt+ cells were grown in F12
medium (Invitrogen Corp., Life Technologies,
Inc./Gibco, Grand Island, NY, USA)
supplemented with 5% fetal bovine serum
(Omega Scientific, Tarzana, CA, USA) and
1% penicillin/streptomycin (Invitrogen Corp.,
Life Technologies, Inc., Grand Island, NY,
USA) at 37°C in a humid atmosphere (5%
CO2). Standard mutagenesis protocols for the
selection of the 6-thioguanine resistance
(6TGR) gpt – phenotype in G12 cells were fol-
lowed as previously described (12,13,17). In
brief, cells were treated with soluble potassium
chromate (K2CrO4; Fisher, Pittsburgh, PA,
USA) (5–50 µM) or insoluble BaCrO4
(0.05–0.25 µg/cm2), then allowed a 7-day
expression period in nonselective F12 medium
prior to being plated for mutant selection in
10 µg/mL 6TGF12 medium [reviewed in
Klein et al. (18)]. K2CrO4 treatments were for
2 hr (12,19,20) at 37°C in magnesium-supple-
mented salts glucose medium (SGM; 50 mM
HEPES buffer, 100 mM NaCl, 5 mM KCl, 2
mM CaCl2, 0.8 mM MgSO4, pH 7.2).
Insoluble BaCrO4 treatments were for 24 hr at
37°C in complete F12 medium rather than in
SGM because the G12 cells do not tolerate salt
buffers for lengthy exposures, even when sup-
plemented with glucose, as we have previously
reported (19). In contrast to the K2CrO4
exposures (2 hr), the BaCrO4 exposures were
for 24 hr to allow either dissolution of Cr from
the particles, if it occurs, or to allow time for
phagocytic uptake of the particles by the G12
cells similar to that which occurs for insoluble
nickel compounds (20, 21). Also similar to the
way in which we have previously studied insol-
uble nickel compounds (20,21), the insoluble
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Epigenetic gene silencing by aberrant DNA methylation of gene promoter regions is a nonmutagenic
but heritable epigenetic mechanism that may mistakenly cause the silencing of important cancer-
related tumor suppressor genes. Using a transgenic, V79-derived, mammalian cell line (G12) that
contains a bacterial gpt reporter gene in its DNA, we can study carcinogen-induced gene inactivation
by mutagenic as well as epigenetic DNA methylation mechanisms. Whereas numerous carcinogens
have previously been shown to be mutagenic in these cells, a few carcinogens, including nickel,
diethylstilbestrol, and X-rays, are also capable of silencing the G12 cell gpt transgene by aberrant
DNA methylation. Here we report for the ﬁrst time that carcinogenic potassium chromate salts can
also induce aberrant DNA methylation in this system. In contrast insoluble barium chromate pro-
duced significant level of mutations in these cells but did not cause DNA methylation changes
associated with transgene expression. Key words: chromate, DNA methylation, gpt transgene, V79
Chinese hamster cells. Environ Health Perspect 110(suppl 5):739–743 (2002).
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New York University School of Medicine, Nelson Institute of Environmental Medicine, New York, New York, USABaCrO4 doses are expressed as micrograms
BaCrO4 per square centimeter surface area of
the tissue culture dish, as these insoluble
particles (sized at 0.4–0.6 µM) will tend to
settle out during the 24-hr exposure time.
The dose range of K2CrO4 or BaCrO4 cho-
sen for mutagenesis studies corresponds to
those doses that fell within the comprehensive
20–100% survival curve generated for each
Cr compound.
For the collection of independent
chromate-induced 6TGR clones, individually
treated minicultures of 104 G12 cells were
treated with various doses of K2CrO4 in
35-mm wells of 6-well dishes, and the cells
were handled as independent cultures through-
out the entire 6TG selection process. Only one
mutant per treated population was isolated and
frozen for further analysis. The doses of each
compound chosen for subsequent mutant
isolation were either the maximal mutagenic
dose (BaCrO4) or a variety of doses (K2CrO4).
All reagents and biochemicals were acquired
from Sigma Biochemical Company (St. Louis,
MO, USA), unless otherwise speciﬁed.
Analysis of Deletion Mutations and
DNA Methylation in G12 Cells
A panel of independent 6TGR mutants/
epimutants derived from the various chromate
treatments was evaluated for deletion or methy-
lation of the transgene. High molecular weight
DNA was extracted from 0.5 to 1 × 107
mutant G12 cells following standard nonphe-
nol extraction protocols and was screened by
polymerase chain reaction (PCR) to detect
total or partial deletions of the gpt target gene
as per Klein et al. (13). The single PCR
primer set used generates a single 561-bp
PCR amplification product from G12 cells
and their nondeleted mutants.
The methylation status of the gpt
transgene and its proximal 5´ promoter region
was examined on Southern blots for all non-
deletion mutants as previously described (14).
In brief, Hpa II (CCGG) or Hae II(GCGC)
digested Eco RV fragments of G12 DNA con-
taining the gpt transgene and proximal pro-
moter regions were separated in agarose, then
transferred to Nytran Supercharge (Schleicher
and Schuell, Keene, NH, USA) membranes
by capillary transfer or vacuum blotting and
UV linked (Stratalinker, Stratagene, La Jolla,
CA, USA) to the membrane. Blots were pre-
hybridized for 6 hr at 68°C (in 1% nonfat dry
milk, 0.1 mM EDTA, 6% NaH2PO4, 7%
sodium dodecyl sulfate, pH 7.0 ), followed by
overnight probe hybridization in a fresh solu-
tion of the same buffer with 10% dextran sul-
fate. Probes derived from the pSV2gpt
plasmid that was originally transfected into
V79 cells to create the G12 cells were labeled
to a high specific activity (>109 counts per
min/µg DNA) by random priming or PCR
incorporation of 32P. The hybridized mem-
branes were imaged and analyzed using a
Storm 860 PhosphoImager (NYU/NIEHS
Center, Molecular Biology Facility Core).
Reversion Studies in G12 Cells
To conﬁrm the methylation silencing of the
gpt transgene induced by chromate, 5-azacyti-
dine–induced reversion to HAT (100 µM
hypoxanthine, 1 µM aminopterin, 100 µM
thymidine) resistance was examined. In brief,
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Figure 1. Survival and mutagenesis of G12 cells treated with K2CrO4. K2CrO4 exposures were for 2 hr at 37°C
in magnesium-supplemented SGM. Clonal cell survival (% control) is depicted in (A), and the corresponding
mutagenesis is shown in (B). The data points represent the mean of 3–5 independent experiments, with
error bars denoting standard error of the means.
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Figure 2. Survival and mutagenesis of G12 cells treated with BaCrO4.Insoluble BaCrO4 treatments were for
24 hr at 37°C in complete F12 medium. Clonal cell survival (% control) is depicted in (A), and the corre-
sponding mutagenesis is shown in (B). The data points represent the means of 2–3 independent experi-
ments, with standard error of the means shown by error bars for doses where at least three data points
were available. 
Table 1. Chromium-induced deletion frequencies.
Deletion
Cells Gene Mutagen (% total)
G12 gpt K2CrO4 8/15 (53)
G12 gpt BaCrO4 8/23 (33)
V79 hprt K2CrO4 14/27 (52)a
aOnly exons 3 and 6 of the hprt gene were screened in
these mutants.
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Figure 3. PCR amplification of the gpt sequence in G12 cells and K2CrO4-induced G12 mutants. MWM,
molecular weight marker. High molecular weight DNA was extracted from mutant G12 cells and was
screened by PCR to detect total or partial deletions of the gpt target genes as shown on agarose gels.
The single PCR primer set used generates a single 561-bp PCR ampliﬁcation product from G12 cells and
any nondeleted mutants. K2CrO4 exposure doses (2 hr in SGM) were as follows: 12Cr1L and 1S = 5 µM;
12Cr2L and 2S = 10 µM; 12Cr3L and 3S = 20 µM; 12Cr4L and 4S = 30 µM; 12Cr5L and 5S = 40 µM; and
12Cr6L and 6S = 50 µM.
740 VOLUME 110 | SUPPLEMENT 5 | OCTOBER 2002 • Environmental Health PerspectivesEnvironmental Health Perspectives • VOLUME 110 | SUPPLEMENT 5 | OCTOBER 2002 741
a representative sampling of G12 epimutants
that exhibited evidence of DNA methylation
on Southern blots were treated with 5-azacy-
tidine (5 µM) for 48 hr followed by a 24-hr
recovery period prior to selection of revertants
in F12HAT medium (14,21). HAT-resistant
clones were stained and counted after 2–3
weeks in selection.
Results
Figure 1 shows that K2CrO4 (5–50 µM) was
mutagenic in G12 cells over a completely toxic
dose range, with maximal mutation induction
(3× background levels) peaking at 40 µM
(about 40% survival), as we have previously
reported (19,20). Similarly, insoluble BaCrO4
was mutagenic (Figure 2) in G12 cells, with a
maximal mutation peak (3.5× background)
observed at 0.15 µg/cm2 (75% survival).
Notable in both of these ﬁgures (Figures 1B,
2B) is the peak in mutagenesis levels followed
by a decline, and the broadness of the error
bars. These features are characteristic of the
mutagenesis proﬁles generated by us and oth-
ers in various mammalian cells by Cr (22,23),
by other metals such as nickel oxides (12,20),
and by oxidants including nitric oxide, hydro-
gen peroxide, and glucose oxidase (24).
Interestingly, chromate-induced mutagenesis
at the Na+K+-ATPase (ouabain resistance) gene
was not recoverable in either G12 or their par-
ent V79 cells (data not shown). These results
support our ﬁndings, described below, show-
ing that chromate primarily induced a mixture
of deletion mutants and methylation variants
that would not be recoverable at the Na+K+-
ATPase gene due to the tight limitations of the
ouabain resistance selection mechanisms (12).
K2CrO4 generated gpt transgene deletions
in 5 of the 12 6TGR G12 mutants depicted in
the PCR panel in Figure 3. These mutants
were induced by an increasing range of
K2CrO4 doses as follows: 12Cr1L and 1S by 5
µM; 12Cr2L and 2S by 10 µM; 12Cr3L and
3S by 20 µM; 12Cr4L and 4S by 30 µM;
12Cr5L and 5S by 40 µM; and 12Cr6L and
6S by 50 µM. Among 15 K2CrO4-generated
G12 mutants we have examined to date, 53%
exhibited complete deletion of the gpt
transgene. This frequency of chromate-
induced deletions was in the same range of
transgene deletion frequencies previously
described for approximately equitoxic doses of
X-rays (48%) and bleomycin (57%) in these
same cells (13). In comparison, about 20% of
spontaneous G12 mutants exhibit transgene
deletions (13). Additionally, the chromate-
induced deletion frequency in G12 cells was
identical to that observed for deletions of
exons 3 and 6 of the hprt gene (14/27 = 52%)
in the parental V79 cells (Table 1). Figure 4
shows PCR-deletion screening of a sampling
of BaCrO4–induced mutations in G12 cells.
In total, we have identiﬁed 33% (8/24) dele-
tion mutants from G12 cells exposed to insol-
uble BaCrO4. This deletion frequency is
slightly less than that noted above for K2CrO4
mutants. Until now, very little was known
about the type of mutations that would be
induced by insoluble BaCrO4 (4).
DNA methylation analysis of the gpt
transgene and 5´ promoter region in several
K2CrO4-induced mutants is shown in
Figure 5. Compared with the completely
unmethylated status of control untreated G12
DNA (lanes 2 and 3), there is evidence of par-
tial methylation of the gpt transgene in Cr vari-
ants Cr3S, Cr4S, Cr5S, Cr5L, Cr6L, and
Cr7L, as detected by the presence of a 0.98-kb
band in the HpaII lanes (Figure 5A) and the
1.7-kb band in the HaeII lanes (Figure 5B). In
these studies, almost all nondeleted chromate-
induced variants exhibit partial methylation of
the transgene. In comparison, only 10% of
spontaneous G12 mutants have their transgene
silenced by DNA hypermethylation. The Cr
mutant Cr1L was previously shown to be
deleted by PCR (Figure 3). In contrast to this
K2CrO4 data, insoluble BaCrO4 did not
induce any DNA methylation changes in G12
cells, as shown in the representative panel of
mutants examined (Figure 6).
Similar to the partial DNA methylation
pattern shown above (Figure 5) for the Cr
methylation variants and for some X-ray G12
variants (Figure 7, lanes 3 and 4), nickel-
induced variants also exhibited some degree
of incomplete or partial methylation of the
G12 transgene by nickel (14), as evidenced
by acquisition of 1.7-kb HaeII bands accom-
panied by incomplete loss of the unmethy-
lated 1.2-kb bands. This could represent
either incomplete methylation or reversion
loss of methylation in some cells. In the Cr
studies it is possible that the partial methyla-
tion we observe is due to the short exposure
to chromate (2 hr), and we are presently
examining the DNA methylation status of
G12 cells exposed to chromate for longer
exposures (24–48 hr) as well as chronic expo-
sures (2–6 weeks) to low chromate doses.
However, others have reported that 1- to 2-hr
exposures of mammalian cells to soluble chro-
mate is sufﬁcient to induce a variety of tran-
scription regulators, including AP1, nuclear
factor kappa B, and Sp1 (2,8).
A measurable degree of spontaneous
reversion, accompanied by demonstrable loss
of DNA methylation, occurs in nickel-
induced methylation variant cell popula-
tions, allowing the gpt transgene to regain
functional expression in a substantial pro-
portion of the cells (14). However, the Cr-
induced variant cells discussed herein were
continuously grown in 6TGR selection until
the time of DNA extraction, thus eliminat-
ing the possibility of any spontaneous rever-
sion at this point. Furthermore, epigenetic
silencing of gpt in G12 cells can be com-
pletely reversed by treatment of silenced cells
with the methylation inhibitor 5-azacytidine
(14) or with a combination of 5-azacytidine
and the histone deacetylase inhibitor tricho-
statin A (15), as demonstrated for nickel-
silenced cells. We show here (Table 2) that
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Figure 4. PCR ampliﬁcation of the gpt sequence in
G12 cells and BaCrO4-induced G12 mutants. High
molecular weight DNA was screened by PCR to
detect total or partial deletions of the gpt target
gene, as shown on agarose gels. All BaCrO4 expo-
sures were 0.15 µg/cm2 (24 hr) in complete F12.
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Figure 5. Methylation of the gpt gene in K2CrO4-induced G12 mutants and variants. Lane 1 = EcoRV-
digested control G12 DNA. Lanes 2 and 3 are unmethylated control G12 DNA. All genomic DNA was ﬁrst
digested with EcoRV, then DNA in lanes labeled A were subsequently digested with Hpa II, and those
labeled B were digested with Hae II. Cr3S to Cr7L are K2CrO4 -induced 6TG-resistant G12 variants. All vari-
ants except the Cr1L deletion mutant show methylation of the gpt gene, as observed by the 1.7-kb band in
HaeII digests (B) and 0.98-kb band in HpaII digests (A). In Cr1L, the gpt gene was deleted, as previously
shown by PCR. The mutants denoted by shorthand in this ﬁgure as Cr3S, Cr1L, etc., are identical to those
labeled as 12Cr3S, 12Cr1L, etc. described elsewhere.chromate-induced methylation variants are
also subject to 5-azacytidine–mediated rever-
sion of transgene silencing, as are methyla-
tion variants induced by X-rays and DES
(data not shown). The reversion frequencies
shown in Table 2 are similar to those previ-
ously reported for nickel-induced methyla-
tion variants (14). Whereas spontaneous
reversion of nickel-induced variants occurs
at a frequency of about 10–4, we have not
yet investigated the spontaneous reversion of
the chromate variants, but we anticipate it
will be similar.
Discussion
Based on our knowledge of the myriad
Cr-induced mutagenic, clastogenic, and
carcinogenic effects (5), including evidence
characterizing numerous Cr-induced base sub-
stitution mutations (22,25), it was not surpris-
ing that such a high frequency of gpt deletions
was recovered in the G12 mutation experi-
ments. Although it was possible that Cr-
induced mutagenic base substitutions could
have occurred in the PCR primer sites to elim-
inate gpt sequence ampliﬁcation, the transgene
deletions observed by PCR screening were
confirmed on Southern blots of genomic
DNA. These deletions are not inconsistent
with the activity of reactive oxygen or other
reactive radicals that may be generated during
GSH or other reductant-mediated intracellular
reduction of Cr(VI) to Cr(III). In support of
this, Cr induced DNA strand breaks when
reduced by ascorbate or glutathione [reviewed
in Klein (5)]. Furthermore, Cr(VI)/GSH- or
Cr(VI)/peroxide-induced oxidation-mediated
deletions of the pZ189 vector supF gene in
CV-1 cells have been reported for 43% of the
mutants recovered and analyzed in the experi-
ments of Dixon and collaborators (3,26).
Similar to K2CrO4, insoluble BaCrO4
also yielded a generous proportion of G12
deletion mutants. Indeed, little is known
about the mutagenic spectrum that can be
induced in mammalian cells by BaCrO4 (4).
Compared with sodium, calcium, and lead
chromates, which generate reactive oxygen
radicals in serum-supplemented culture
medium, BaCrO4 was reported to be inactive
in ROS generation under similar circum-
stances (27). Also in contrast to soluble
K2CrO4, BaCrO4 was much less active in
inducing pulmonary inflammation in rat
inhalation studies (28). It will be interesting
to identify the DNA sequence mutations
within the nondeleted transgene in the as yet
uncharacterized BaCrO4 mutants.
Although Cr is mutagenic in a variety of
bacterial and mammalian systems [reviewed
in DeFlora et al. (4) and Klein (5)], the
mutagenic potential of Cr(VI) exposures is
ambiguous in the literature. Yang et al. (22)
analyzed the mutagenic specificity of base
substitution mutations caused by Cr(VI) in
the hprt gene of Chinese hamster ovary cells,
finding predominantly AT→ TA or
AT→ CG mutations. These results corre-
lated with previous studies of chromate
mutagenesis in Salmonella strain TA102,
which is sensitive to mutations in A/T-rich
sequences (29). In contrast, Chen and Thilly
(25) described four hotspots for Cr mutage-
nesis in the endogenous human hprt gene,
speciﬁcally observing mutations of CG→ AT
or TA, CG→ AT, and AT→ TA. Similarly,
Liu et al. (3) thoroughly characterized the
mutations induced by potassium dichromate
in the supF gene of pZ189 shuttle vectors in
cultured mammalian (CV-1 monkey) cells,
ﬁnding a predominance of mutations at GC
base pairs (GC→ AT, GC→ CG, GC→ TA).
These results are in general agreement with
Chen and Thilly (25). In closely examining
the sequence context of the reported muta-
tions in the Liu study (3), it becomes evi-
dent that many but not all of the chromate
mutations are located at guanines and
cytosines in CpG DNA sites. Our ongoing
examination of the entire gpt sequence in
nondeleted methylation variants will reveal
whether intragenic CpG sites within the
transgene are similarly mutated by Cr at
guanine or cytosine bases. This would not
be unexpected, as there is already sufficient
precedent for some other carcinogens to
react at CpG sites within relevant cancer
genes. For example, studies of benzo[a]pyrene
mutations in p53 have defined predominant
mutation hotspots at guanines in methylated
CpG sites within the coding exons of p53
(30–32). Although the mutation of a CpG
site can easily be envisioned to result in the
aberrant loss of normal DNA methylation, it
is also possible that mutation of CpG sites
may lead to aberrant DNA hypermethyla-
tion, perhaps through as yet undefined
DNA repair-mediated processes or by per-
turbations of those normal processes.
Our observations of DNA methylation
silencing and 5-azacytidine–mediated reversion
of transgene expression following chromate
exposure were unexpected. Previously we
reported that carcinogenic nickel (14) and the
synthetic estrogen DES (16) could silence
expression of the gpt transgene in G12 cells.
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Figure 6. Methylation blot of BaCrO4-induced mutants of G12 cells. Lane 1 = EcoRV-digested control G12
DNA. Lanes 2 and 3 are unmethylated control G12 DNA. All lanes labeled A are digested with Hpa II, and
those labeled B are digested with Hae II, after intial digestion with EcoRV. 12CrI1 to 12CrI5 are BaCrO4-
induced, 6TG-resistant G12 variants. The gpt gene was deleted in 12CrI1 and 12CrI2, as shown above by
PCR. There is a complete lack of induced DNA methylation in mutants 12CrI3, 12CrI4, and 12CrI5.Subsequently, we added X-rays and now
chromate to the growing list of carcinogens
that have the capacity to induce DNA methy-
lation silencing of susceptible target genes.
These carcinogens, with the exception of
nickel, all induce a mixed spectrum comprising
varying proportions of classic gene mutations,
transgene deletions, and altered transgene pro-
moter methylation that result in the inactiva-
tion, loss, or silencing of the G12 reporter
transgene. All epigenetically silenced variants
examined to date can be reactivated by 5-aza-
cytidine to reexpress the transgene, regardless
of the carcinogen (nickel, chromate, DES,
X-rays) that caused the aberrant promoter or
transgene methylation. Some degree of sponta-
neous reversion also occurs for most variants.
In contrast to nickel-induced methylation,
which causes formation of tightly condensed
heterochromatin, our preliminary data suggest
that the methylation induced by chromate,
DES, and X-rays may be transient, and per-
haps weaker, as suggested by DNase resistance
studies. Temporal studies are underway to fur-
ther characterize the persistence of the altered
DNA methylation state, as the methylation
blots shown herein clearly demonstrate partial
transgene methylation, as discussed above.
The relevance of these findings can be
applied to the human cancer scenario, for
which the loss of expression of a multitude
of tumor suppressor and DNA repair has
now been shown to result from aberrant
DNA methylation (33). In human tumors,
aberrant DNA hypermethylation of the
CDKN2/p16/MTS1 gene, for example, has
been described for about 33% of breast
cancers, 60% of prostate cancers, 23% of
renal cancers, and 92% of colon cancers cell
lines, as well as in 31% of primary breast
cancer tumors and 40% of primary colon
cancers (34). DNA repair genes including
O6-methylguanine-DNA methyltransferase
and the mismatch repair genes hMLH1and
hMSH6 (35,36) are also subject to aberrant
transcription silencing in tumors. Even the
human telomerase gene is subject to epige-
netic DNA methylation silencing, which
may have significant ramifications in the
carcinogenic process (37). Recent studies of
DNA hypermethylation in certain cancers
suggest that methylation changes in gene
expression may in fact be early events in the
carcinogenic process (35,38).
In conclusion, accumulating evidence
from retrospective studies of archived and
fresh breast, ovarian, colon, and many other
human tumors has provided substantial evi-
dence that a variety of tumor suppressor and
other crucial DNA repair and damage control
genes can be inactivated by DNA methyla-
tion silencing. However, it is unknown from
these tumor studies whether these DNA
methylation changes occur early in tumorige-
nesis, possibly resulting from environmental
exposures, or if they are late effects perhaps
related to establishment, selection, and per-
petuation of the tumorigenic phenotype (39).
Our data support the emerging concept that
gene-speciﬁc environmental exposure–related
changes in DNA methylation may be early
events in the tumorigenic process.
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Table 2. 5-Azacytidine–induced reversion of
chromate-induced methylation variants.
Reversion
Cells Mutagen frequency
12Cr3S 20 µM K2CrO4 8.16 × 10-2
12Cr5S 40 µM K2CrO4 8.75 × 10-2
12Cr5L 40 µM K2CrO4 1.05 × 10-2
12Cr6L 50 µM K2CrO4 6.33 × 10-2
12Cr7L 50 µM K2CrO4 3.16 × 10-2